Biomarkers guiding systemic therapy

Haeseong Park details testing for mismatch repair/MSI, PD-L1, HER2/ERBB2, and CLDN18.2 to guide targeted and immunotherapies.

Play episode from 09:17

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!